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Background: Cigarette smoking promotes vascular endothelial damage and accelerates progression of atheroscle-
rosis. The purpose of this study was to examine whether the circulating level of vascular endothelium-enriched
microRNA-126 (miR-126), which is highlighted as a regulator of gene expression, would serve as a novel
biomarker for recovery from smoking-related vascular damage.
Methods: Middle-aged male smokers (n = 30) were enrolled and instructed to stop smoking. Their clinical
proﬁles and laboratory ﬁndings including expression of miR-126 were investigated before and after 8 weeks of
smoking cessation. Serum levels of cotinine, metabolites of nicotine, were measured to conﬁrm smoking
cessation. Endothelial function for peripheral small vessels was assessed and expressed as reactive hyperemia
peripheral arterial tonometry (RH-PAT) index. The expression of miR-126 in plasma was analyzed by quantita-
tive real-time PCR.
Results:At baseline, serumcotinine levelswere inversely correlatedwith RH-PAT index (r=−0.48, P b 0.01) and
positively correlated with levels of metabolic parameters such as non-HDL cholesterol (r = 0.53, P b 0.01) and
HOMA-IR (r= 0.52, P b 0.01). The RH-PAT index was not signiﬁcantly changed after 8 weeks in all subjects, be-
cause only 13 subjects could attain smoking cessation. However, changes in the RH-PAT index showed a
signiﬁcant correlation with those in systolic blood pressure (r=−0.54, P b 0.01). In smokers who completely
attained smoking cessation (n= 13), RH-PAT index and plasma levels of miR-126 were signiﬁcantly increased
(P b 0.05, respectively).
Conclusions: Endothelial damage was improved and plasma levels of circulating miR-126 were increased after
8 weeks of smoking cessation. These ﬁndings suggested a potential use of miR-126 as a biomarker for recovery
from smoking-induced vascular damage.
© 2015 The Authors. Published by Elsevier Ireland Ltd. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Cigarette smoking promotes vascular endothelial damage and
accelerates progression of atherosclerosis [1–4]. Nicotine, the main
extract of cigarette smoking, is the major substance underlying its
addictiveness, and affects the cardiovascular system itself [5–7].
Cigarette smoking increases cardiovascular risk even at low-doses or
with low-tar [8,9]. Thus, cigarette smoking and smoking extracts haveal Medicine and Hypertension,
nce, Kawasumi 1, Mizuho-cho,
21; fax: +81 52 852 3796.
giura).
eliability and freedom from bias
land Ltd. This is an open access articla close association with cardiovascular diseases. Moreover, the inﬂu-
ence of cigarette smoking may last from a few months to years after
smoking cessation. Therefore, numerous efforts have been made to
identify reliable and predictive biomarkers to detect the early signs of
recovery from smoking-induced endothelial damage. In our previous
study, smoking cessation for 8 weeks improved endothelial function
although plasma serotonin level was not signiﬁcantly decreased [10].
On the other hand, circulatingmicroRNAs (miRNAs) are highlighted
as new biomarkers for various diseases and pathophysiologies [11–13].
MiRNAs are a class of short single-stranded non-coding RNAs that
regulate cellular functions through degradation and translational
repression of miRNAs that contain complementary sequences, and are
known to be released from cells into circulation in a stable form, and
therefore are explored for their potential as biomarkers in cardio-
vascular disease [12–14]. Especially, miRNA-126 (miR-126), as ane under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Table 1
Characteristics of subjects at baseline and after 8 weeks of instruction to stop smoking.
Variable (n= 30) P value
Baseline After 8 weeks
Age (years old) 42 ± 10 – –
BMI (kg/m2) 22.4 ± 3.0 22.5 ± 3.0 NS
Systolic BP (mm Hg) 126 ± 14 127 ± 12 NS
Diastolic BP (mm Hg) 80 ± 10 81 ± 10 NS
WBC (/10−3 μl) 5.7 ± 1.4 6.0 ± 1.7 NS
Hemoglobin (g/dl) 14.8 ± 1.5 15.8 ± 1.8 b0.01
Platelet (/10−4 μl) 22.1 ± 5.3 21.8 ± 6.0 NS
Creatinine (mg/dl) 0.76 ± 0.09 0.78 ± 0.08 NS
Total cholesterol (mg/dl) 190 ± 30 194 ± 29 NS
HDL cholesterol (mg/dl) 58 ± 14 58 ± 13 NS
non-HDL cholesterol (mg/dl) 133 ± 36 136 ± 34 NS
LDL cholesterol (mg/dl) 107 ± 29 109 ± 28 NS
Triglyceride (mg/dl) 164 ± 165 155 ± 116 NS
Fasting plasma glucose (mg/dl) 92 ± 9 94 ± 13 NS
HOMA-IR 0.88 ± 0.76 1.86 ± 3.4 NS
hs-CRP (mg/l) 0.06 ± 0.14 0.29 ± 1.05 NS
TDS 7.2 ± 1.5 – –
FTND 4.5 ± 2.0 – –
Cotinine (ng/ml) 176 ± 200 99 ± 128 b0.01
RH-PAT index 1.80 ± 0.38 1.95 ± 0.60 NS
Data are expressed asmean±SD. BMI: bodymass index,WBC:white blood cell count, BP:
blood pressure, HDL: high-density lipoprotein, LDL: low-density lipoprotein, HOMA-IR:
homeostasis model assessment of insulin resistance, hs-CRP: high sensitive-CRP, TDS: to-
bacco dependence screener, FTND: Fagerstrome test for nicotine dependence, RH-PAT: re-
active hyperemia of peripheral arterial tonometry.
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vascular homeostasis and angiogenesis [12,15,16]. Therefore, we
hypothesized that the expression of miR-126 would serve as a novel
biomarker for recovery from smoking-related endothelial damage in
middle-aged habitual smokers.Fig. 1. Correlation between serum cotinine levels and endothelial function, and metabolic para
peripheral arterial tonometry (RH-PAT) index. b. Correlation between serum cotinine level and
and non-high-density lipoprotein cholesterol (non-HDL-C). d. Correlation between serum coti2. Methods
Apparently healthy male smokers were enrolled and instructed to
stop smoking. Their clinical proﬁles including endothelial function and
laboratory ﬁndings including miRNAs were investigated before and
after 8 weeks of smoking cessation. The expression of miRNA in platelet
poor plasma was analyzed by quantitative real-time PCR. Endothelial
function was assessed by reactive hyperemia of peripheral arterial
tonometry (PAT) using End-PAT 2000 [17,18].2.1. Study subjects
Middle-aged male subjects who were habitual cigarette smokers
were enrolled. Subjects were recruited from outpatients who came to
our hospital with common cold or lifestyle diseases such as low risk
hypertension or dyslipidemia. At least 1 month after the ﬁrst visit,
their physical condition was examined and enrolled. Age adjusted ap-
parently healthy subjects were also enrolled as non-smoking controls.
Patients with obvious organ damage, diabetes mellitus, complication
of malignant neoplasm or active inﬂammatory disease, medical history
of cardiovascular events, or taking medications were excluded.
Informed consent was obtained from each subject. The study was ap-
proved by the Ethical Committee of Nagoya City University Graduate
School of Medical Sciences and carried out in accordance with the
Declaration of Helsinki of the World Medical Association.
After enrollment, endothelial functionwas assessed by reactive hyper-
emia, and subsequently peripheral blood was taken for biochemical
analysis. Strong precaution was taken to obtain platelet poor plasma
samples suitable for serotonin assays as we previously described [19].
Blood pressurewasmeasured in the non-dominant arm using a validat-
ed oscillometric technique (HEM-7070; Omron Corporation, Kyoto,
Japan) at the seated position on the same day.meters at baseline. a. Correlation between serum cotinine level and reactive hyperemia of
high-density lipoprotein cholesterol (HDL-C). c. Correlation between serum cotinine level
nine level and homeostasis model assessment of insulin resistance (HOMA-IR).
Fig. 2. Changes of systolic blood pressure (SBP) and endothelial function from baseline to 8weeks after instruction to stop smoking. a. Percent change of SBPwas inversely correlatedwith
percent change of reactive hyperemia of peripheral arterial tonometry (RH-PAT) index. b. RH-PAT index was signiﬁcantly increased in subjects who decreased SBP.
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function was assessed after 8 weeks of smoking cessation. Similarly,
peripheral blood was taken for biochemical analysis to compare
the clinical proﬁles before and after smoking cessation. Nicotine
dependence was assessed by a tobacco dependence screener (TDS)
[20]. Serum levels of cotinine, principal metabolites of nicotine, were
measured to conﬁrm smoking cessation after 8 weeks [21,22].Table 22.2. Biochemical analysis
Blood was taken in early morning after overnight fasting. Strict
precautions were taken to obtain platelet poor plasma. Serum total
cholesterol (total-C), high-density lipoprotein cholesterol (HDL-C) and
triglyceride (TG) were determined by standard laboratory assays. High
sensitive-C-reactive protein (hs-CRP) was determined by a latex-
enhanced immunonephelometric assay on a BN II analyzer (Dade
Behring, Marburg, Germany). Fasting plasma glucose was measured
by radioimmunoassay. Serum cotinine levels were measured by ELISA
according to the manufacturer's instructions (Cozart, Abingdon, UK).Characteristics of the subjects who completely attained 8 week smoking cessation.
Variable (n= 13) P value
Baseline After 8 weeks
Age (years old) 44 ± 11 – –
BMI (kg/m2) 23.3 ± 2.5 23.3 ± 2.6 NS2.3. RNA isolation and quantitative real-time PCR
Themethods of isolation of total RNA and quantitative real-time PCR
of miRNA were performed as previously described [23].Systolic BP (mm Hg) 128 ± 18 127 ± 13 NS
Diastolic BP (mm Hg) 79 ± 9 81 ± 9 NS
WBC (/10−3 μl) 5.7 ± 1.7 5.9 ± 1.1 NS
Hemoglobin (g/dl) 14.3 ± 1.2 15.3 ± 0.9 b0.01
Platelet (/10−4 μl) 23.4 ± 4.0 22.1 ± 6.8 NS
Creatinine (mg/dl) 0.76 ± 0.07 0.75 ± 0.06 NS
Total cholesterol (mg/dl) 193 ± 30 201 ± 32 b0.05
HDL cholesterol (mg/dl) 61 ± 17 59 ± 15 NS
Non-HDL cholesterol (mg/dl) 132 ± 40 142 ± 40 NS
LDL cholesterol (mg/dl) 104 ± 33 109 ± 33 NS2.4. Determination of vascular endothelial function
Endothelial function in peripheral small vessels was assessed by
reactive hyperemia of peripheral arterial tonometry (RH-PAT) in the
morning under an overnight fasting condition. RH-PAT was measured
using an End-PAT 2000 device (Itamar Medical Ltd., Caesarea, Israel)
and expressed as RH-PAT index according to previous reports [17,18].Triglyceride (mg/dl) 161 ± 105 175 ± 154 NS
Fasting plasma glucose (mg/dl) 93 ± 10 94 ± 13 NS
HOMA-IR 0.76 ± 0.39 0.76 ± 0.40 NS
hs-CRP (mg/l) 0.04 ± 0.04 0.12 ± 0.22 NS
TDS 7.4 ± 1.2 – –
FTND 3.8 ± 1.7 – –
Cotinine (ng/ml) 134 ± 120 7.5 ± 6.4 b0.01
RH-PAT index 1.82 ± 0.35 2.2 ± 0.66 b0.05
Data are expressed asmean±SD. BMI: bodymass index,WBC:white blood cell count, BP:
blood pressure, HDL: high-density lipoprotein, LDL: low-density lipoprotein, HOMA-IR:
homeostasis model assessment of insulin resistance, hs-CRP: high sensitive-CRP,
FTND: Fagerstrome test for nicotine dependence, RH-PAT index: reactive hyperemia of
peripheral arterial tonometry.2.5. Statistic analysis
Data were expressed as mean value ± standard deviation (SD).
Comparison of continuous variables was performed by paired or
unpaired t-test as appropriate. Correlations between the parameters
were assessed by calculating Pearson's correlation coefﬁcient (r).
Parameters not expressing a normal distribution were converted by
log-transformation (hs-CRP). Differences of P b 0.05 were considered
statistically signiﬁcant.3. Results
Characteristics of the subjects enrolled in this study are described in
Table 1. At baseline, serum cotinine levels were inversely correlated
with endothelial function expressed as RH-PAT index (r = −0.48,
P b 0.01) and HDL-C level, and positively correlated with levels of
non-HDL-C (r = 0.53, P b 0.01) and HOMA-IR (r = 0.52, P b 0.01)
(Fig. 1).
The RH-PAT index was not signiﬁcantly changed after 8 weeks in
all subjects, because only 13 subjects could attain smoking cessation
(Table 1). However, % change of systolic blood pressure was signiﬁcant-
ly correlatedwith % change of RH-PAT index (Fig. 2a). Furthermore, sub-
jects with decreased systolic blood pressure exhibited a signiﬁcantly
improved RH-PAT index (Fig. 2b).
Next, smokers who completely attained smoking cessation were
analyzed separately. Characteristics of the subjects who completely
attained smoking cessation are described in Table 2. They indicate
Fig. 3.Analysis in subjectswho completely attained smoking cessation during 8weeks and in subjectswho could not attain smoking cessation. a. Subjects who completely attained 8week
smoking cessation showed a signiﬁcant improvement in reactive hyperemia of peripheral arterial tonometry (RH-PAT) index. b. Subjects who completely attained 8 week smoking
cessation exhibited a signiﬁcant increase in circulating levels of microRNA-126 (miR-126).
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after 8 weeks of smoking cessation (P b 0.05, respectively) (Fig. 3).
However, RH-PAT index and expression levels of miR-126 did not
showa signiﬁcant difference between subjectswho completely attained
8 weeks of smoking cessation and subjects who could not attain
smoking cessation.
4. Discussion
The main ﬁndings of this study were that (1) serum cotinine levels
were correlated inversely with endothelial function and positively
with metabolic parameters, (2) % change of blood pressure was signiﬁ-
cantly correlatedwith% change of endothelial function, and (3) smokers
who completely attained smoking cessation showed improvement of
endothelial function and increase in expression of plasma miR-126
after 8 weeks.
Recent reports have revealed that upregulation of miR-126 was
observed in progression of angiogenesis and maintenance of vascular
integrity [24]. Therefore, miR-126 might have a protective role in ho-
meostasis for vascular endothelium. In fact, atherosclerotic subjects
with coronary artery disease and diabetes mellitus were reported to
have lower circulating levels of miR-126 in clinical studies [25,26].
Although our previous study did not show a difference in expression
of miR-126 between subjects with andwithout coronary artery disease,
the heterogeneity of characteristics of subjects including differences of
medications might be involved [23]. Moreover, samples of plasma
used in that study might not be platelet poor plasma. In the present
study, subjects were non-medicated habitual smokers who might
have early atherosclerosis. Strict precautions were also taken to obtain
platelet poor plasma. The plasma level of miR-126 increased rapidly
after 8 weeks of smoking cessation with concomitant improvement
of endothelial function. However, signiﬁcant correlation was not
transversely observed between the level of miR-126 and RH-PAT
index. A detailed mechanism was not elucidated but widely inter-
spersed levels of miR-126 expression at baseline might be related.
Therefore, the quantitative assessment of miR-126 levels in the platelet
poor plasma may have diagnostic potential to detect early recovery of
endothelial function particularly in identical subjectswhowere habitual
smokers.
Johnson et al. reported that smoking cessation improved the
endothelial function assessed by FMD after 1 year despite body weight
gain [27]. We evaluated the endothelial function after 8 weeks of
smoking cessation, and conﬁrmed the improvement of endothelial
function in subjectswho completely attained smoking cessation despitean increase of total-C level. Subjects with decreased systolic blood
pressure showed increased RH-PAT index after 8 weeks. The decrease
of blood pressure may be due to an improvement of endothelial func-
tion and relaxation of vascular tonus. To conﬁrm smoking cessation,
we measured serum cotinine levels. At baseline, the cotinine level was
positively correlated with atherogenic factors including non-HDL-C
and homeostasis model assessment of insulin resistance (HOMA-IR)
and inversely correlated with HDL-C and RH-PAT index. This result
also supports the favorable effects of smoking cessation and subsequent
decrease in cotinine levels.
5. Study limitations
The present study is limited by the small number of subjects studied.
Moreover, enrolled subjects were limited to middle-aged smokers and
comparatively non-heavy smokers. Further study with a larger popula-
tion and a longer follow-up period will clarify the relationship of
smoking cessation and miR-126, and endothelial function in cigarette
smokers.
6. Conclusions
Vascular endothelial damage was improved and plasma levels of
endothelium-enriched circulating miR-126 were increased after
8 weeks of smoking cessation. These results suggested a potential use
of miR-126 as a sensitive and informative biomarker for recovery from
smoking-induced endothelial damage.
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